Go Pro
→ SPCX Warning - and Worst News for Stocks in 50 Years (From TradeSmith) (Ad)tc pixel Free IINN Stock Alerts

Inspira Technologies OXY B.H.N. (IINN) Competitors

Inspira Technologies OXY B.H.N. logo
$1.43 -0.08 (-5.30%)
As of 07/2/2026
Compare

IINN vs. INFU, RXST, FOCL, EMBC, and KRMD

Should you buy Inspira Technologies OXY B.H.N. stock or one of its competitors? MarketBeat compares Inspira Technologies OXY B.H.N. with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Inspira Technologies OXY B.H.N. include InfuSystem (INFU), RxSight (RXST), FocalTherics (FOCL), Embecta (EMBC), and KORU Medical Systems (KRMD). These companies are all part of the "medical equipment" industry.

How does Inspira Technologies OXY B.H.N. compare to InfuSystem?

Inspira Technologies OXY B.H.N. (NASDAQ:IINN) and InfuSystem (NYSE:INFU) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, media sentiment, institutional ownership, analyst recommendations, profitability, dividends and risk.

In the previous week, Inspira Technologies OXY B.H.N. had 1 more articles in the media than InfuSystem. MarketBeat recorded 1 mentions for Inspira Technologies OXY B.H.N. and 0 mentions for InfuSystem. InfuSystem's average media sentiment score of 1.00 beat Inspira Technologies OXY B.H.N.'s score of 0.00 indicating that InfuSystem is being referred to more favorably in the news media.

Company Overall Sentiment
Inspira Technologies OXY B.H.N. Neutral
InfuSystem Positive

12.7% of Inspira Technologies OXY B.H.N. shares are held by institutional investors. Comparatively, 71.1% of InfuSystem shares are held by institutional investors. 29.4% of Inspira Technologies OXY B.H.N. shares are held by company insiders. Comparatively, 10.8% of InfuSystem shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

InfuSystem has a consensus target price of $15.00, indicating a potential upside of 47.64%. Given InfuSystem's stronger consensus rating and higher possible upside, analysts clearly believe InfuSystem is more favorable than Inspira Technologies OXY B.H.N..

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
InfuSystem
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

Inspira Technologies OXY B.H.N. has a beta of 2.16, indicating that its stock price is 116% more volatile than the broader market. Comparatively, InfuSystem has a beta of 1.4, indicating that its stock price is 40% more volatile than the broader market.

InfuSystem has higher revenue and earnings than Inspira Technologies OXY B.H.N..

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspira Technologies OXY B.H.N.$289K177.88-$13.22MN/AN/A
InfuSystem$142.40M1.44$870K$0.3826.74

InfuSystem has a net margin of 1.12% compared to Inspira Technologies OXY B.H.N.'s net margin of 0.00%. InfuSystem's return on equity of 2.78% beat Inspira Technologies OXY B.H.N.'s return on equity.

Company Net Margins Return on Equity Return on Assets
Inspira Technologies OXY B.H.N.N/A N/A N/A
InfuSystem 1.12%2.78%1.41%

Summary

InfuSystem beats Inspira Technologies OXY B.H.N. on 10 of the 14 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to RxSight?

Inspira Technologies OXY B.H.N. (NASDAQ:IINN) and RxSight (NASDAQ:RXST) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, earnings, dividends, institutional ownership, profitability, analyst recommendations, risk and media sentiment.

Inspira Technologies OXY B.H.N. has higher earnings, but lower revenue than RxSight.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspira Technologies OXY B.H.N.$289K177.88-$13.22MN/AN/A
RxSight$134.48M1.73-$38.94M-$1.13N/A

In the previous week, Inspira Technologies OXY B.H.N. and Inspira Technologies OXY B.H.N. both had 1 articles in the media. Inspira Technologies OXY B.H.N.'s average media sentiment score of 0.00 equaled RxSight'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inspira Technologies OXY B.H.N.
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
RxSight
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Inspira Technologies OXY B.H.N. has a beta of 2.16, indicating that its stock price is 116% more volatile than the broader market. Comparatively, RxSight has a beta of 1.15, indicating that its stock price is 15% more volatile than the broader market.

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to RxSight's net margin of -36.58%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat RxSight's return on equity.

Company Net Margins Return on Equity Return on Assets
Inspira Technologies OXY B.H.N.N/A N/A N/A
RxSight -36.58%-17.01%-15.12%

12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. Comparatively, 78.8% of RxSight shares are owned by institutional investors. 29.4% of Inspira Technologies OXY B.H.N. shares are owned by insiders. Comparatively, 10.1% of RxSight shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

RxSight has a consensus price target of $9.44, indicating a potential upside of 68.35%. Given RxSight's stronger consensus rating and higher probable upside, analysts plainly believe RxSight is more favorable than Inspira Technologies OXY B.H.N..

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
RxSight
3 Sell rating(s)
10 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
1.93

Summary

Inspira Technologies OXY B.H.N. beats RxSight on 7 of the 12 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to FocalTherics?

Inspira Technologies OXY B.H.N. (NASDAQ:IINN) and FocalTherics (NASDAQ:FOCL) are both small-cap medical equipment companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends.

Inspira Technologies OXY B.H.N. has a beta of 2.16, indicating that its share price is 116% more volatile than the broader market. Comparatively, FocalTherics has a beta of -0.04, indicating that its share price is 104% less volatile than the broader market.

12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. Comparatively, 62.7% of FocalTherics shares are owned by institutional investors. 29.4% of Inspira Technologies OXY B.H.N. shares are owned by company insiders. Comparatively, 10.1% of FocalTherics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Inspira Technologies OXY B.H.N. has higher earnings, but lower revenue than FocalTherics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspira Technologies OXY B.H.N.$289K177.88-$13.22MN/AN/A
FocalTherics$70.53M2.75-$29.25M-$0.81N/A

In the previous week, FocalTherics had 1 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 2 mentions for FocalTherics and 1 mentions for Inspira Technologies OXY B.H.N.. FocalTherics' average media sentiment score of 0.97 beat Inspira Technologies OXY B.H.N.'s score of 0.00 indicating that FocalTherics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inspira Technologies OXY B.H.N.
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
FocalTherics
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

FocalTherics has a consensus target price of $6.00, indicating a potential upside of 15.83%. Given FocalTherics' stronger consensus rating and higher possible upside, analysts plainly believe FocalTherics is more favorable than Inspira Technologies OXY B.H.N..

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
FocalTherics
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to FocalTherics' net margin of -41.47%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat FocalTherics' return on equity.

Company Net Margins Return on Equity Return on Assets
Inspira Technologies OXY B.H.N.N/A N/A N/A
FocalTherics -41.47%-137.61%-40.62%

Summary

Inspira Technologies OXY B.H.N. and FocalTherics tied by winning 7 of the 14 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to Embecta?

Inspira Technologies OXY B.H.N. (NASDAQ:IINN) and Embecta (NASDAQ:EMBC) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, profitability, analyst recommendations, valuation and media sentiment.

Embecta has a consensus price target of $11.00, indicating a potential upside of 228.36%. Given Embecta's stronger consensus rating and higher possible upside, analysts clearly believe Embecta is more favorable than Inspira Technologies OXY B.H.N..

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Embecta
3 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.40

In the previous week, Embecta had 28 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 29 mentions for Embecta and 1 mentions for Inspira Technologies OXY B.H.N.. Embecta's average media sentiment score of 0.08 beat Inspira Technologies OXY B.H.N.'s score of 0.00 indicating that Embecta is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inspira Technologies OXY B.H.N.
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Embecta
1 Very Positive mention(s)
0 Positive mention(s)
28 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. Comparatively, 93.8% of Embecta shares are owned by institutional investors. 29.4% of Inspira Technologies OXY B.H.N. shares are owned by insiders. Comparatively, 1.3% of Embecta shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Embecta has a net margin of 10.73% compared to Inspira Technologies OXY B.H.N.'s net margin of 0.00%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Embecta's return on equity.

Company Net Margins Return on Equity Return on Assets
Inspira Technologies OXY B.H.N.N/A N/A N/A
Embecta 10.73%-23.96%14.12%

Embecta has higher revenue and earnings than Inspira Technologies OXY B.H.N..

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspira Technologies OXY B.H.N.$289K177.88-$13.22MN/AN/A
Embecta$1.08B0.18$95.40M$1.901.76

Inspira Technologies OXY B.H.N. has a beta of 2.16, indicating that its share price is 116% more volatile than the broader market. Comparatively, Embecta has a beta of 0.83, indicating that its share price is 17% less volatile than the broader market.

Summary

Embecta beats Inspira Technologies OXY B.H.N. on 9 of the 13 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to KORU Medical Systems?

Inspira Technologies OXY B.H.N. (NASDAQ:IINN) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, valuation, institutional ownership, media sentiment and risk.

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to KORU Medical Systems' net margin of -5.27%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat KORU Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Inspira Technologies OXY B.H.N.N/A N/A N/A
KORU Medical Systems -5.27%-13.61%-8.33%

Inspira Technologies OXY B.H.N. has a beta of 2.16, meaning that its share price is 116% more volatile than the broader market. Comparatively, KORU Medical Systems has a beta of 0.41, meaning that its share price is 59% less volatile than the broader market.

KORU Medical Systems has a consensus target price of $7.25, suggesting a potential upside of 61.47%. Given KORU Medical Systems' stronger consensus rating and higher probable upside, analysts clearly believe KORU Medical Systems is more favorable than Inspira Technologies OXY B.H.N..

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
KORU Medical Systems
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60

12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are owned by institutional investors. 29.4% of Inspira Technologies OXY B.H.N. shares are owned by company insiders. Comparatively, 18.5% of KORU Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

KORU Medical Systems has higher revenue and earnings than Inspira Technologies OXY B.H.N..

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspira Technologies OXY B.H.N.$289K177.88-$13.22MN/AN/A
KORU Medical Systems$43.26M4.77-$2.64M-$0.05N/A

In the previous week, KORU Medical Systems had 1 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 2 mentions for KORU Medical Systems and 1 mentions for Inspira Technologies OXY B.H.N.. Inspira Technologies OXY B.H.N.'s average media sentiment score of 0.00 equaled KORU Medical Systems'average media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inspira Technologies OXY B.H.N.
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
KORU Medical Systems
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

KORU Medical Systems beats Inspira Technologies OXY B.H.N. on 7 of the 13 factors compared between the two stocks.

Get Inspira Technologies OXY B.H.N. News Delivered to You Automatically

Sign up to receive the latest news and ratings for IINN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IINN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IINN vs. The Competition

Export
MetricInspira Technologies OXY B.H.N.MED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$51.41M$7.57B$7.16B$12.48B
Dividend YieldN/A1.32%2.66%6.52%
P/E RatioN/A52.1228.0224.70
Price / Sales177.8849.46540.3799.49
Price / CashN/A26.7249.2657.09
Price / Book23.837.4810.966.46
Net Income-$13.22M$159.19M$3.57B$337.01M
7 Day Performance-11.18%-0.39%2.12%1.69%
1 Month Performance-23.53%-0.43%5.25%3.81%
1 Year Performance21.70%3.14%33.29%23.90%

Inspira Technologies OXY B.H.N. Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IINN
Inspira Technologies OXY B.H.N.
0.0282 of 5 stars		$1.43
-5.3%		N/A+21.7%$51.41M$289KN/A20
INFU
InfuSystem
4.2595 of 5 stars		$10.02
+3.8%		$15.00
+49.7%		+64.9%$202.22M$142.40M167.03410
RXST
RxSight
2.251 of 5 stars		$5.17
+7.3%		$9.44
+82.7%		-57.5%$199.53M$134.48MN/A220
FOCL
FocalTherics
3.047 of 5 stars		$5.20
+0.4%		$6.00
+15.4%		N/A$194.16M$70.53MN/A230
EMBC
Embecta
4.5456 of 5 stars		$3.36
+3.1%		$11.00
+227.4%		-67.5%$193.41M$1.08B1.771,850

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:IINN) was last updated on 7/5/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
From the man who predicted 2008 crash…
Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...
Porter & Company | Sponsoredtc pixel